Covenant Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-560
Closed -$256K – 199
2023
Q4
$256K Hold
560
– – 0.08% 156
2023
Q3
$272K Hold
560
– – 0.1% 147
2023
Q2
$250K Hold
560
– – 0.09% 154
2023
Q1
$272K Sell
560
-12
-2% -$5.93K 0.1% 149
2022
Q4
$293K Hold
572
– – 0.12% 135
2022
Q3
$278K Hold
572
– – 0.14% 134
2022
Q2
$268K Hold
572
– – 0.12% 148
2022
Q1
$249K Sell
572
-137
-19% -$57.3K 0.1% 165
2021
Q4
$329K Hold
709
– – 0.12% 152
2021
Q3
$276K Hold
709
– – 0.11% 160
2021
Q2
$314K Hold
709
– – 0.12% 160
2021
Q1
$297K Sell
709
-70
-9% -$27.9K 0.12% 159
2020
Q4
$320K Hold
779
– – 0.14% 141
2020
Q3
$322K Sell
779
-66
-8% -$26.5K 0.16% 145
2020
Q2
$328K Buy
845
+5
+0.6% +$1.87K 0.15% 149
2020
Q1
$264K Sell
840
-95
-10% -$32K 0.14% 148
2019
Q4
$343K Hold
935
– – 0.16% 140
2019
Q3
$239K Buy
+935
New +$262K 0.13% 155

Other funds holding HUM

Covenant Partners's HUM Position: Q1 2024 in Review

Covenant Partners sold out of Humana (HUM) in Q1 2024, closing a stake of 560 shares — an estimated $256K sold.

Covenant Partners first reported a position in HUM in Q3 2019 and held it in 18 quarters. The position peaked at $343K in Q4 2019. 1,031 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Covenant Partners reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Covenant Partners sold 560 Humana shares in Q1 2024, an estimated $256K.
  • Covenant Partners first reported a position in Humana in Q3 2019 and held it in 18 quarters.
  • Covenant Partners's Humana position peaked at $343K in Q4 2019.
  • 1,031 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Covenant Partners's 13F filing for Q1 2024, filed 30 Apr 2024.